Individual Articles - Sep/Oct 2019 - Volume 23, Number 5 |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 356
|
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019
Pg. 358-364
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
|
Sep/Oct 2019
Pg. 366-375
|
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
|
Sep/Oct 2019
Pg. 376-381
|
Threading the Needle
Brunner Scott
|
Sep/Oct 2019
Pg. 383-385
|
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
|
Sep/Oct 2019
Pg. 387-391
|
Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 393-396
|
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 399-402
|
Calculations
Stockton Shelly J
|
Sep/Oct 2019
Pg. 404
|
Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 406
|
Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 407
|
Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 408
|
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 409
|
Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 410
|
Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 411
|
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 412
|
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 413
|
Stability of Furosemide 5 mg/mL in Polypropylene Syringes
van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
|
Sep/Oct 2019
Pg. 414-417
|
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián
|
Sep/Oct 2019
Pg. 418-421
|
The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 422-427
|
The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 428-433
|
Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics
Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
|
Sep/Oct 2019
Pg. 434-437
|
Erratum: McNulty JP, Hahn K. Compounded oral ketamine for severe depression, anxiety, and pain in a hospice patient with end-stage chronic obstructive pulmonary disease, cardiopulmonary failure, and severe : A case report. IJPC. 2012; 16(5): 364–368.
|
Sep/Oct 2019
Pg. 438
|
Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191.
|
Sep/Oct 2019
Pg. 438
|